National Research Center, Egypt   Report issue

Government Phase 1 Phase 2 Phase 4
Founded: Cairo Egypt (1956)

Organization Overview

First Clinical Trial
2016
NCT03572959
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Assistant lecturer of Anesthesia, ICU, and Pain Relief | Mona Mohamed Taha | National Research Center, Egypt | National Research Centre, Egypt | Sherine Adel Nasry

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 2)

Communicable Diseases (Phase 2)

Coronavirus Infections (Phase 2)

Infections (Phase 2)

Infertility (Phase 4)

Infertility, Female (Phase 4)

Lichen Planus (Phase 4)

Lichen Planus, Oral (Phase 4)

Respiratory Distress Syndrome (Phase 2)

Respiratory Distress Syndrome, Newborn (Phase 2)

Severe Acute Respiratory Syndrome (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 15